Utah Retirement Systems Seagen Inc. Transaction History

Utah Retirement Systems

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$187.64 - $206.25 $37,528 - $41,250	-200 Reduced 0.83%	24,040 $4.63 Million
Q1 2023 May 15, 2023	BUY	$127.59 - $203.08 $12,759 - $20,308	100 Added 0.41%	24,240 $4.91 Million
Q4 2022 Feb 15, 2023	SELL	$117.37 - $139.17 $23,474 - $27,833	-200 Reduced 0.82%	24,140 $3.1 Million
Q3 2022 Nov 14, 2022	BUY	$135.27 - $180.11 $40,581 - $54,033	300 Added 1.25%	24,340 $3.33 Million
Q1 2022 May 13, 2022	SELL	$119.61 - $157.85 $11,961 - $15,785	-100 Reduced 0.41%	24,040 $3.46 Million
Q3 2021 Nov 16, 2021	SELL	$142.45 - $169.82 $185,184 - $220,766	-1,300 Reduced 5.11%	24,140 $4.1 Million
Q2 2021 Aug 16, 2021	BUY	$135.08 - $161.1 $148,588 - $177,210	1,100 Added 4.52%	25,440 $4.02 Million
Q1 2021 May 17, 2021	SELL	$137.51 - $190.8 $151,261 - $209,880	-1,100 Reduced 4.32%	24,340 $3.38 Million
Q4 2020 Feb 16, 2021	BUY	$164.63 - $211.93 $4.19 Million - $5.39 Million	25,440 New	25,440 $4.46 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Utah Retirement Systems, based on Form 13F filings with the SEC.

Stay updated on Utah Retirement Systems with notifications on news.